Should I buy or sell Afya stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Afya in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AFYA shares. View AFYA analyst ratings or view top-rated stocks .

What is Afya's stock price target for 2024?

2 Wall Street research analysts have issued 1-year price targets for Afya's shares. Their AFYA share price targets range from $20.50 to $23.00. On average, they expect the company's stock price to reach $21.75 in the next twelve months. This suggests a possible upside of 6.4% from the stock's current price. View analysts price targets for AFYA or view top-rated stocks among Wall Street analysts .

How have AFYA shares performed in 2023?

Afya's stock was trading at $15.62 on January 1st, 2023. Since then, AFYA stock has increased by 30.9% and is now trading at $20.45. View the best growth stocks for 2023 here .

When is Afya's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 27th 2024. View our AFYA earnings forecast .

How were Afya's earnings last quarter?

Afya Limited (NASDAQ:AFYA) announced its quarterly earnings results on Wednesday, May, 26th. The company reported $1.16 EPS for the quarter, missing analysts' consensus estimates of $1.56 by $0.40. The business had revenue of $72.15 million for the quarter, compared to analyst estimates of $72.96 million. Afya had a trailing twelve-month return on equity of 15.08% and a net margin of 13.15%. Read the conference call transcript .

What ETFs hold Afya's stock?

ETFs with the largest weight of Afya (NASDAQ:AFYA) stock in their portfolio include BNY Mellon Sustainable Global Emerging Markets ETF (BKES) . VanEck Brazil Small-Cap ETF (BRF) .

What guidance has Afya issued on next quarter's earnings?

Afya issued an update on its FY 2023 earnings guidance on Monday, November, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $563.44 million-$583.93 million, compared to the consensus revenue estimate of $572.69 million.

What other stocks do shareholders of Afya own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Afya investors own include Pfizer (PFE) , Cisco Systems (CSCO) , Procter & Gamble (PG) , RTX (RTX) , Abbott Laboratories (ABT) , CVS Health (CVS) , Johnson & Johnson (JNJ) , Alibaba Group (BABA) and CSX (CSX) .

(AFYA) raised $233 million in an initial public offering (IPO) on Friday, July 19th 2019. The company issued 13,700,000 shares at a price of $16.00-$18.00 per share. BofA Merrill Lynch, Goldman Sachs, UBS Investment Bank, Itaú BBA, Morgan Stanley, BTG and Pactual XP Investments acted as the underwriters for the IPO.

Who are Afya's major shareholders?

Afya's stock is owned by many different retail and institutional investors. Top institutional investors include Bamco Inc. NY (3.59%), Perpetual Ltd (1.08%), Massachusetts Financial Services Co. MA (0.65%), DekaBank Deutsche Girozentrale (0.29%), Itau Unibanco Holding S.A. (0.15%) and Renaissance Group LLC (0.15%).

How do I buy shares of Afya?

Shares of AFYA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Afya Stock Price, News & Analysis (NASDAQ:AFYA)

$20.45

-0.01 (-0.05%)

(As of 12/1/2023 ET)

Compare

Today's Range: $20.27
▼
$20.63
50-Day Range: $14.80
▼
$20.56
52-Week Range: $9.66
▼
$21.18

Volume: 97,198 shs
Average Volume: 229,695 shs
Market Capitalization: $1.92 billion

P/E Ratio: 26.22
Dividend Yield: N/A
Price Target: $21.75

Afya MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 6.4% Upside
$21.75 Price Target
Short Interest: Healthy
3.50% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.08
Based on 5 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 31.20%
From $1.25 to $1.64 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.19 out of 5 stars

Consumer Discretionary Sector

130th out of 264 stocks

Educational Services Industry

12th out of 22 stocks

1.3

Analyst's Opinion

Consensus Rating
Afya has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 1 buy rating, 1 hold rating, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $21.75, Afya has a forecasted upside of 6.4% from its current price of $20.45.
Amount of Analyst Coverage
Afya has only been the subject of 2 research reports in the past 90 days.

4.0

Short Interest

Percentage of Shares Shorted
3.50% of the float of Afya has been sold short.
Short Interest Ratio / Days to Cover
Afya has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Afya has recently decreased by 1.90%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Afya does not currently pay a dividend.
Dividend Growth
Afya does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for AFYA.

2.8

News and Social Media Coverage

News Sentiment
Afya has a news sentiment score of 0.08. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Consumer Discretionary companies.
News Coverage This Week
MarketBeat has tracked 5 news articles for Afya this week, compared to 2 articles on an average week.
Search Interest
4 people have searched for AFYA on MarketBeat in the last 30 days.
MarketBeat Follows
7 people have added Afya to their MarketBeat watchlist in the last 30 days. This is an increase of 133% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Afya insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.80% of the stock of Afya is held by insiders.
Percentage Held by Institutions
60.13% of the stock of Afya is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

3.8

Earnings and Valuation

Earnings Growth
Earnings for Afya are expected to grow by 31.20% in the coming year, from $1.25 to $1.64 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Afya is 26.22, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 116.74.
Price to Earnings Ratio vs. Sector
The P/E ratio of Afya is 26.22, which means that it is trading at a more expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 21.70.
Price to Earnings Growth Ratio
Afya has a PEG Ratio of 0.93. PEG Ratios below 1 indicate that a company could be undervalued.
Price to Book Value per Share Ratio
Afya has a P/B Ratio of 2.64. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Afya Stock (NASDAQ:AFYA)

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools. The company also provides digital health services, such as subscription-based mobile app and website portal that focuses on assisting health professionals and students with clinical decision-making through tools, such as medical calculators, charts, and updated content, as well as prescriptions, clinical scores, medical procedures and laboratory exams, and others. It offers health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition, and biomedicine; and degree programs and courses in other subjects and disciplines, including undergraduate and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering, and pedagogy. In addition, the company provides medical postgraduate specialization programs; printed and digital content; and an online medical education platform and practical medical training services. The company was founded in 1999 and is headquartered in Nova Lima, Brazil.

AFYA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

AFYA Stock News Headlines

December 1, 2023 | msn.com

NHIF set to end Uhuru's EduAfya Medical Scheme after five years

November 28, 2023 | americanbankingnews.com

Afya's (AFYA) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co.

December 3, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

November 27, 2023 | msn.com

JP Morgan Downgrades Afya Ltd - (AFYA)

November 23, 2023 | finance.yahoo.com

PRDO or AFYA: Which Is the Better Value Stock Right Now?

November 17, 2023 | finance.yahoo.com

Afya (AFYA) Is Considered a Good Investment by Brokers: Is That True?

November 15, 2023 | finance.yahoo.com

Afya Limited (NASDAQ:AFYA) Q3 2023 Earnings Call Transcript

November 14, 2023 | finance.yahoo.com

Why Afya Stock Edged Higher Today

December 3, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

November 14, 2023 | finance.yahoo.com

Q3 2023 Afya Ltd Earnings Call

November 13, 2023 | msn.com

Afya GAAP EPS of R$1.03, revenue of R$726.48M

November 13, 2023 | finance.yahoo.com

Afya Limited Announces Third Quarter and Nine Months 2023 Financial Results

November 13, 2023 | msn.com

KMPDC Seeks Punitive Measures Against 6,901 License Defaulters

November 12, 2023 | markets.businessinsider.com

What Wall Street expects from Afya's earnings

November 8, 2023 | finance.yahoo.com

Is There An Opportunity With Afya Limited's (NASDAQ:AFYA) 50% Undervaluation?

November 7, 2023 | finance.yahoo.com

Afya (AFYA) Rises Higher Than Market: Key Facts

November 7, 2023 | seekingalpha.com

Afya: Poised For Growth, But Likely Fairly Valued

November 6, 2023 | finance.yahoo.com

Afya (AFYA) Beats Stock Market Upswing: What Investors Need to Know

November 6, 2023 | msn.com

Honey or sugar: Debate surrounding Ruto's sweetener choice

November 3, 2023 | nytimes.com

As a Teen, She Loved Video Games. Now She’s Using A.I. to Try to Quash Malaria.

November 1, 2023 | msn.com

Afya announces additional purchase of 15% of Centro de Ciências em Saúde de Itajubá

November 1, 2023 | msn.com

Kenya: Women Correct Historical Injustices, Build Climate Resilience Through Cash Pooling

October 31, 2023 | finance.yahoo.com

Afya (AFYA) Stock Drops Despite Market Gains: Important Facts to Note

October 31, 2023 | finance.yahoo.com

Afya Limited Announces Additional Purchase of 15% of Centro de Ciências em Saúde de Itajubá S.A.

October 25, 2023 | finance.yahoo.com

Afya (AFYA) Advances While Market Declines: Some Information for Investors

October 23, 2023 | msn.com

The decline of HIV mother-to-child-transmissions in Mara

October 13, 2023 | msn.com

Morgan Stanley Upgrades Afya Ltd - (AFYA)

See More Headlines

Receive AFYA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Afya and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 5/26/2021
Today: 12/02/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 3/27/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Educational services
Sub-Industry: N/A
Sector: Consumer Discretionary
Current Symbol: NASDAQ:AFYA
CUSIP: N/A
CIK: 1771007
Web: www.afya.com.br
Phone: 553135157550
Fax: N/A
Employees: 8,708
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $21.75
High Stock Price Target: $23.00
Low Stock Price Target: $20.50
Potential Upside/Downside: +6.4%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 2 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.78
Trailing P/E Ratio: 26.22
Forward P/E Ratio: 16.36
P/E Growth: 0.93
Net Income: $72.36 million
Net Margins: 13.15%
Pretax Margin: 15.25%
Return on Equity: 15.08%
Return on Assets: 6.69%

Debt

Debt-to-Equity Ratio: 0.49
Current Ratio: 1.18
Quick Ratio: 1.18

Sales & Book Value

Annual Sales: $451.09 million
Price / Sales: 4.25
Cash Flow: $1.43 per share
Price / Cash Flow: 14.33
Book Value: $7.76 per share
Price / Book: 2.64

Miscellaneous

Outstanding Shares: 93,720,000
Free Float: 92,973,000
Market Cap: $1.92 billion
Optionable: Not Optionable
Beta: 0.98

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Mr. Virgilio Deloy Capobianco Gibbon (Age 47)
Chief Executive Officer
Mr. Luis Andre Carpintero Blanco (Age 50)
Chief Financial Officer
Renata Couto
Investor Relations Executive Manager
Mr. Julio Eduardo Razente de Angeli (Age 50)
Vice President of Continuing Education & Innovation

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

AFYA Stock Analysis - Frequently Asked Questions

Should I buy or sell Afya stock right now?: 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Afya in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" AFYA shares.
View AFYA analyst ratings or view top-rated stocks.
What is Afya's stock price target for 2024?: 2 Wall Street research analysts have issued 1-year price targets for Afya's shares. Their AFYA share price targets range from $20.50 to $23.00. On average, they expect the company's stock price to reach $21.75 in the next twelve months. This suggests a possible upside of 6.4% from the stock's current price.
View analysts price targets for AFYA or view top-rated stocks among Wall Street analysts.
How have AFYA shares performed in 2023?: Afya's stock was trading at $15.62 on January 1st, 2023. Since then, AFYA stock has increased by 30.9% and is now trading at $20.45.
View the best growth stocks for 2023 here.
When is Afya's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, March 27th 2024.
View our AFYA earnings forecast.
How were Afya's earnings last quarter?: Afya Limited (NASDAQ:AFYA) announced its quarterly earnings results on Wednesday, May, 26th. The company reported $1.16 EPS for the quarter, missing analysts' consensus estimates of $1.56 by $0.40. The business had revenue of $72.15 million for the quarter, compared to analyst estimates of $72.96 million. Afya had a trailing twelve-month return on equity of 15.08% and a net margin of 13.15%.
Read the conference call transcript.
What ETFs hold Afya's stock?: ETFs with the largest weight of Afya (NASDAQ:AFYA) stock in their portfolio include BNY Mellon Sustainable Global Emerging Markets ETF (BKES).VanEck Brazil Small-Cap ETF (BRF).

What guidance has Afya issued on next quarter's earnings?: Afya issued an update on its FY 2023 earnings guidance on Monday, November, 13th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $563.44 million-$583.93 million, compared to the consensus revenue estimate of $572.69 million.
What other stocks do shareholders of Afya own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Afya investors own include Pfizer (PFE), Cisco Systems (CSCO), Procter & Gamble (PG), RTX (RTX), Abbott Laboratories (ABT), CVS Health (CVS), Johnson & Johnson (JNJ), Alibaba Group (BABA) and CSX (CSX).
When did Afya IPO?: (AFYA) raised $233 million in an initial public offering (IPO) on Friday, July 19th 2019. The company issued 13,700,000 shares at a price of $16.00-$18.00 per share. BofA Merrill Lynch, Goldman Sachs, UBS Investment Bank, Itaú BBA, Morgan Stanley, BTG and Pactual XP Investments acted as the underwriters for the IPO.
Who are Afya's major shareholders?: Afya's stock is owned by many different retail and institutional investors. Top institutional investors include Bamco Inc. NY (3.59%), Perpetual Ltd (1.08%), Massachusetts Financial Services Co. MA (0.65%), DekaBank Deutsche Girozentrale (0.29%), Itau Unibanco Holding S.A. (0.15%) and Renaissance Group LLC (0.15%).
How do I buy shares of Afya?: Shares of AFYA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:AFYA) was last updated on 12/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial